What we know

Anthropic has shared early progress in applying its AI model, Claude, to speed up drug development processes. The company highlights Claude’s use in tasks like reviewing scientific literature, generating research hypotheses, and analyzing data relevant to drug discovery.

Why it matters

Using AI to assist drug development could potentially reduce the time and cost required to bring new medicines to market. Anthropic’s application of Claude to these tasks suggests a growing role for large language models in biomedical research. However, the information comes from Anthropic’s own blog post, and no independent studies have yet confirmed the effectiveness or accuracy of Claude in this domain.

What is still unknown

No independent tests have verified Claude’s accuracy or performance in drug development tasks. Details about which languages Claude supports for these applications and any plans for broader availability remain undisclosed.